Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Jung, Hyun Jun ^a   Lim, Jung Suk ^a   Choi, Hyo Jung ^a   Lee, Mi Suk ^a   Kim, Jong Ho ^a,b   Kim, Sang Yeob ^a   Kim, Soyoun ^a   Kim, Eunjung ^a   Kwon, Tae Hwan ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; ARGININE; SMALL INTERFERING RNA; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; GENE DELIVERY SYSTEM; GENETIC TRANSDUCTION; KIDNEY CELL; NONHUMAN; OSMOLALITY; PEPTIDE SYNTHESIS; PH; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; RAT;

ANIMALS; AQUAPORIN 2; CELL LINE; FLUORESCEIN; GENE KNOCKDOWN TECHNIQUES; KIDNEY TUBULES, COLLECTING; PEPTIDES; RECEPTORS, VASOPRESSIN; RNA, SMALL INTERFERING;

RATTUS;

EID: 84862976500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040010     Document Type: Article

References (35)

1. Seyhan AA, (2011) RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet 130: 583-605.
2. Gewirtz AM, (2007) On future's doorstep: RNA interference and the pharmacopeia of tomorrow. J Clin Invest 117: 3612-3614.
3. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-43.
4. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, et al. (2010) Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 84: 2490-2501.
5. Zhang K, Wang Q, Xie Y, Mor G, Sega E, et al. (2008) Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. RNA 14: 577-583.
6. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, et al. (1994) Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95.
7. Bouley R, Hawthorn G, Russo LM, Lin HY, Ausiello DA, et al. (2006) Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment. Biol Cell 98: 215-232.
8. Bouley R, Sun TX, Chenard M, McLaughlin M, McKee M, et al. (2003) Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. Am J Physiol Cell Physiol 285: C750-762.
9. Bouley R, Lin HY, Raychowdhury MK, Marshansky V, Brown D, et al. (2005) Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway. Am J Physiol Cell Physiol 288: C1390-1401.
10. Robben JH, Knoers NV, Deen PM, (2004) Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 15: 5693-5699.
11. Simmons NL, Tivey DR, (1992) The effect of hyperosmotic challenge upon ion transport in cultured renal epithelial layers (MDCK). Pflugers Arch 421: 503-509.
12. Deen PM, Rijss JP, Mulders SM, Errington RJ, van Baal J, et al. (1997) Aquaporin-2 transfection of Madin-Darby canine kidney cells reconstitutes vasopressin-regulated transcellular osmotic water transport. J Am Soc Nephrol 8: 1493-1501.
13. Fisher OZ, Kim T, Dietz SR, Peppas NA, (2009) Enhanced core hydrophobicity, functionalization and cell penetration of polybasic nanomatrices. Pharm Res 26: 51-60.
14. He C, Hu Y, Yin L, Tang C, Yin C, (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31: 3657-3666.
15. Nejsum LN, Zelenina M, Aperia A, Frokiaer J, Nielsen S, (2005) Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol 288: F930-938.
16. Christensen BM, Zelenina M, Aperia A, Nielsen S, (2000) Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-42.
17. Gao J, Yu Y, Zhang Y, Song J, Chen H, et al. (2012) EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 33: 270-282.
18. Tagalakis AD, He L, Saraiva L, Gustafsson KT, Hart SL, (2011) Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery. Biomaterials 32: 6302-6315.
19. Chen J, Jorgensen MR, Thanou M, Miller AD, (2011) Post-coupling strategy enables true receptor-targeted nanoparticles. J RNAi Gene Silencing 7: 449-455.
20. Balhorn R, Brewer L, Corzett M, (2000) DNA condensation by protamine and arginine-rich peptides: analysis of toroid stability using single DNA molecules. Mol Reprod Dev 56: 230-234.
21. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, et al. (2003) Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 278: 11411-11418.
22. van Rossenberg SM, van Keulen AC, Drijfhout JW, Vasto S, Koerten HK, et al. (2004) Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery. Gene Ther 11: 457-464.
23. Bartz R, Fan H, Zhang J, Innocent N, Cherrin C, et al. (2011) Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem J 435: 475-487.
24. Herce HD, Garcia AE, Litt J, Kane RS, Martin P, et al. (2009) Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J 97: 1917-1925.
25. Morris MC, Vidal P, Chaloin L, Heitz F, Divita G, (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 25: 2730-2736.
26. Laufer SD, Restle T, (2008) Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems. Curr Pharm Des 14: 3637-3655.
27. Dominska M, Dykxhoorn DM, (2010) Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci 123: 1183-1189.
28. Rejman J, Oberle V, Zuhorn IS, Hoekstra D, (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377: 159-169.
29. Maupetit J, Tuffery P, Derreumaux P, (2007) A coarse-grained protein force field for folding and structure prediction. Proteins 69: 394-408.
30. Maupetit J, Derreumaux P, Tuffery P, (2010) A fast method for large-scale de novo peptide and miniprotein structure prediction. J Comput Chem 31: 726-738.
31. Maupetit J, Derreumaux P, Tuffery P, (2009) PEP-FOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res 37: W498-503.
32. Kaur H, Garg A, Raghava GP, (2007) PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett 14: 626-631.
33. Stokes JB, Grupp C, Kinne RK, (1987) Purification of rat papillary collecting duct cells: functional and metabolic assessment. Am J Physiol 253: F251-262.
34. Lee YJ, Song IK, Jang KJ, Nielsen J, Frokiaer J, et al. (2007) Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 292: F340-350.
35. Kwon TH, Nielsen J, Kim YH, Knepper MA, Frokiaer J, et al. (2003) Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol 285: F152-165.